News

Alphabet and Microsoft both beat Q1 earnings expectations with strong AI-driven growth—Google Cloud revenue jumped 63% and Microsoft's AI services are running at a $37 billion annual rate. This validates the investment thesis around AI infrastructure and enterprise adoption, reassuring markets that the AI spending cycle is real and monetizable. For Australian investors, this matters because tech-heavy portfolios and ASX-listed cloud operators (like Xero or data-centre plays) often track US cloud giants' momentum; however, the commentary about OpenAI 'sweating' is speculative flavour and shouldn't overshadow the concrete earnings data showing strong fundamentals in cloud and AI services.

The Big Four US tech giants reported earnings simultaneously on Wednesday, with market focus squarely on whether their massive AI infrastructure spending is translating into revenue growth and improving returns on investment. This is crucial for global equity markets—these four companies dominate US indices and have a significant weight in Australian portfolios through ETFs and direct holdings. Investors are essentially deciding whether the AI capex boom justifies current valuations; any disappointment on AI monetisation could trigger a tech selloff that ripples through ASX tech stocks and the broader market.

Equinix, a major global data centre operator, has missed Q1 earnings expectations, triggering a stock selloff. This matters because Equinix is a barometer for cloud computing and AI infrastructure demand—sectors that have driven much of the tech rally. For Australian investors, Equinix operates ASX-listed infrastructure assets and its underperformance could signal softer enterprise spending on cloud and AI deployments, potentially impacting other tech and infrastructure plays in the region.

The Magnificent 7 tech giants are reporting earnings that confirm their massive capital expenditure commitments to AI infrastructure remain on track despite market uncertainty. This matters because these companies drive significant portions of global equity market gains, and their sustained AI investment signals confidence in AI monetisation even as some question ROI timelines. Australian investors should monitor whether this tech strength continues to support the ASX 200, particularly exposure through ETFs and sector plays, while watching if AI capex cycles eventually translate to earnings growth to justify current valuations.

Qualcomm beat Q2 earnings expectations but issued weaker-than-expected Q3 guidance, signalling caution about near-term demand in the semiconductor sector. This mixed result reflects broader uncertainty in chip markets amid inventory normalisations and slowing handset cycles. For Australian investors with tech exposure, this highlights the volatility in semiconductor stocks and suggests the sector's recovery may be more gradual than previously anticipated—watch Qualcomm's commentary on AI demand and customer inventory levels for clues on sector health.

Seagate and NXP have posted stronger-than-expected earnings, reigniting investor appetite for the semiconductor sector after months of caution. This matters because semiconductor strength typically signals improving demand across data centres, AI infrastructure, and consumer electronics—sectors critical to global growth. Australian investors should watch ASX-listed tech and hardware plays for momentum, though direct semiconductor exposure on the ASX is limited; however, this sentiment shift could support broader tech sentiment and benefit Australian IT service providers and data centre operators.

O-I Glass has cut its earnings guidance due to surging global energy costs, signalling broader inflationary pressures affecting manufacturing-heavy industries. This is a cautionary signal for investors in materials and packaging stocks, as energy represents a substantial portion of production costs for glass manufacturers. Australian investors should watch this as a barometer for domestic manufacturers facing similar cost pressures—expect similar guidance cuts from local industrials if energy inflation persists.

AbbVie reported Q1 revenue above expectations but fell short on profit margins, a common pattern when top-line growth doesn't translate to bottom-line strength—often due to higher costs or unfavourable product mix. The company's decision to raise FY26 guidance signals management confidence despite current quarter headwinds, which is generally positive for the stock. Australian investors exposed to US healthcare via ETFs or direct holdings should monitor whether margin pressures persist, as this could impact dividend sustainability, given AbbVie's reputation as a high-yield play.

Biogen has lowered its full-year earnings guidance, citing an unspecified impact from BD (business development or a specific product/deal). This signals operational headwinds—whether from pipeline setbacks, acquisition challenges, or market conditions—that warrant attention. For Australian investors, this matters as Biogen is a major global pharma player; while not ASX-listed, exposure through ETFs or international portfolios is common. Watch for details on what drove the revision and whether it signals broader biotech sector pressures.

Seagate Technology has posted stronger-than-expected earnings results, triggering a renewed rally in its stock price as the market revalues the company upward. This suggests the data storage and hard drive manufacturer is benefiting from recovering demand, possibly tied to AI infrastructure buildout, cloud expansion, or stabilising PC/enterprise cycles. For Australian investors, tech hardware plays like Seagate can serve as bellwethers for broader semiconductor and IT equipment demand; watch whether this momentum extends to other storage and component suppliers.

TotalEnergies has beaten earnings expectations and announced increased shareholder returns, driven by strong oil prices and operational performance. This reflects broader energy sector strength from elevated crude prices, which remains a tailwind for global integrated energy companies and their dividends. Australian investors should note this supports energy sector valuations on the ASX (like $WPL, $STO), though the benefits depend on sustained oil prices above $70–80/bbl.

Robinhood reported Q1 earnings and revenue that fell short of expectations, with crypto revenue and trading volume both declining nearly 50%—a significant headwind given the company's heavy exposure to digital assets. The 10% share price drop reflects investor concern about weakening demand across both traditional and crypto trading segments, suggesting the retail trading boom may be cooling. Australian investors holding $HOOD or considering exposure should monitor whether this signals broader weakness in fintech adoption or is specific to Robinhood's competitive position; the crypto pullback also underscores sentiment volatility in digital assets ahead of potential Fed policy shifts.

Liontown Resources has announced concrete expansion plans for its Kathleen Valley lithium project, triggering early gains in the stock. This is material for Australian lithium investors as Liontown is a significant domestic producer in a sector critical to the energy transition and EV supply chains. The market will be watching for capex requirements, timeline to production, and how this expansion affects returns—key factors for a junior miner's valuation.

Robinhood reported earnings that fell short of analyst expectations on both revenue and net income, suggesting softening demand in retail trading and investing. This matters because Robinhood is a barometer for retail investor activity and market participation—weakness here can signal cooling enthusiasm for equities and options trading. Australian investors should note that retail broking sentiment often correlates with broader market risk appetite; a slowdown at Robinhood could foreshadow similar headwinds for Australian fintech and broking platforms.

Brown-Forman's share price fell after merger negotiations with Pernod Ricard collapsed, removing the possibility of a transformative deal for the US spirits maker. The failed tie-up represents a missed opportunity for scale and synergies in a competitive global alcohol market facing margin pressures. Investors should watch for Brown-Forman's standalone strategic direction and whether either company pursues alternative M&A or shareholder returns; for Australian investors with exposure through diversified funds, this is a minor headwind in the consumer staples space.

Enphase Energy beat Non-GAAP earnings expectations, but underlying US demand weakness signals headwinds in the solar microinverter market. This suggests the company's near-term growth may be constrained despite strong bottom-line execution—a common pattern when supply stabilises after years of tight inventory. Australian renewable energy investors should monitor this as a potential bellwether for the broader solar equipment sector, though ASX-listed solar plays like SunCollections operate differently.

Robinhood reported a 34% quarter-on-quarter drop in crypto revenue during Q1, dragging on overall earnings despite gains from prediction markets. The decline reflects softer crypto trading activity—a key revenue driver for the retail brokerage—which is sensitive to market volatility and investor appetite for digital assets. Australian investors with exposure to fintech or US brokerages should monitor whether this signals weaker retail participation in crypto markets more broadly, though Robinhood's pivot toward prediction markets suggests management sees alternative growth avenues.

General Motors reversed a six-day decline on the back of stronger-than-expected quarterly earnings, signalling resilience in the US auto sector despite ongoing industry headwinds around EV transition and supply chain pressures. For Australian investors, GM results provide a barometer on global consumer spending and the health of the automotive supply chain, which has indirect exposure through local manufacturers and parts suppliers. Watch whether this marks a genuine recovery momentum or merely a technical bounce in a sector facing structural challenges.

Australia's three largest biotech and medical device stocks have underperformed amid company-specific and potentially structural headwinds. Cochlear, CSL, and Pro Medicus face different challenges—ranging from product cycles to market saturation concerns—that suggest this may be more than a temporary cyclical downturn. For Australian investors, this weakness in quality healthcare stocks reflects both domestic earnings pressure and potential shifts in global demand, making it worth monitoring Q1 guidance and management commentary for signs of stabilisation or further deterioration.

Meta faces investor scrutiny ahead of earnings on whether its AI capabilities can generate revenue streams beyond digital advertising—its core business. While the company has successfully used AI to optimise ad targeting and placement, analysts are questioning whether Meta can monetise AI in new ways (enterprise tools, licensing, etc.), which matters because advertising growth is slowing and investors want diversification signals. Watch the earnings call for management commentary on AI product roadmap, enterprise AI initiatives, and revenue contribution from non-advertising AI applications.